Multiple ascending dose of X842

DRUG2 trials

Sponsors

Cinclus Pharma Holding AB, Jiangsu Sinorda Biomedicine Co., Ltd

Conditions

Healthy Volunteers

Early Phase 1

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of X842 in Human: A Single/Multiple Ascending Dose Study

CompletedNCT03105375

Cinclus Pharma Holding ABHealthy Volunteers

Start: 2017-02-21End: 2017-10-12Updated: 2026-06-17

Phase 1

Single-dose and Multiple-dose X842 Phase 1 Study

CompletedNCT04293965

Jiangsu Sinorda Biomedicine Co., LtdHealthy Volunteers

Start: 2018-10-23End: 2019-09-04Updated: 2020-03-06